Announcements

Intimation that while considering the offer made by Dr. A. Velumani, Chairman, MD & CEO to acquire the Company’s shareholding in NHL, both the Audit Committee and the Board of Directors have unanimously decided that the Company has to determine whether it would be beneficial for the Company to hive off the subsidiary or retain it, and for this purpose, it would be advisable to obtain one more valuation report to ensure that the valuation of the subsidiary has been correctly ascertained. The Committee decided to appoint a SEBI approved merchant banker to submit a valuation report, within the shortest possible time, and then take a decision.  None of the Promoter-directors were present during the discussions.

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of Sundaram Mutual Fund, at 10.30 A.M. on Saturday, June 15, 2019.

(ii) Meeting with the representative(s) of Reliance Mutual Fund, at 12.00 Noon on Saturday, June 15, 2019.

(iii) Meeting with the representative(s) of Banyan Capital Advisors LLP, at 10.00 A.M. on Wednesday, June 19, 2019.

(iv) Meeting with the representative(s) of Grandeur Peak Global Advisors, at 02.00 P.M. on Thursday, June 27, 2019.

Intimation that a meeting of the Board of Directors will be held on Thursday, June 13, 2019, to discuss about the offer made by Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of the Company in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of the Company.

Intimation about the following forthcoming meetings:

i) Meeting with the representative(s) of CWC Advisors, at 02.00 P.M. on Tuesday, May 28, 2019 at the Corporate Office of the Company.

ii) Meeting with the representative(s) of Mirabilis Investment Trust, at 04.00 P.M. on Wednesday, May 29, 2019 at the Corporate Office of the Company.

iii) Participation of our representative(s) at “Trinity India- 2019” Organized by Batlivala & Karani Securities India Pvt. Ltd. at Hotel Trident, BKC on Friday, May 31, 2019 from 10.00 A.M., where representatives of various fund houses would be met.

Intimation that  the representative(s) of SAIF Partners would be having a Con-call with us by 3.00 P.M. on Thursday, May 23, 2019.

Intimation about meeting of representative(s) of Anived Portfolio Managers Private Limited, with us at 02.00 P.M. on Wednesday, May 22, 2019 at the Corporate Office of the Company.

Intimation that we had participated in the tender floated by Municipal Corporation of Greater Mumbai (the “MCGM”) for outsourcing of laboratory investigative services “Aapli Chikitsa”, and we have  now received a  letter from MCGM informing us that our tender has been accepted by them; we have been  authorized to provide laboratory investigative services “Aapli Chikitsa” over  a period of 4 years from the commencement of operations, to the MCGM affiliated hospitals and clinics in Western Suburban Zone and City Zone  of Mumbai. The total contract cost of the tender to be executed over the period of 4 years is Rs. 532.27 million, with an assurance of about 60% of total samples test per year; we have since complied with the terms and conditions and are poised to commence the operation on tender awarded by Municipal Corporation of Greater Mumbai for availing laboratory investigative services “Aapli Chikitsa” within next 30 days.

Intimation that at the Board Meeting held on 18-05-2019, when the Auditors pointed out the impairment of investment in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary, Dr. A. Velumani, Chairman, Managing Director & CEO has offered to buy the entire shareholding of the Company in NHL at the current investment value of Rs. 194.67 crores to ensure that there is no loss to the public shareholders; however, all required formalities will be complied with by the Company for such a transaction; we were waiting for the concurrence from the Auditors to intimate this and hence the delay.

Intimation about conference call for Indian and Overseas Investors to be held on 21-05-2019 to discuss about Audited financial results (Stand-alone and Consolidated) for the quarter / full year ended 31-03-2019

Click here to see the invite

Intimation of decisions taken at the Board Meeting held on May 18, 2019, about approval of the Audited Financial Statements (both Stand-alone and Consolidated) for the quarter and the whole year ended 31-03-2019, Recommendation of a Dividend of Rs.20/- per share for 2018-19 and granting of Stock Options for employees for 2018-19.

Intimation about Board Meeting scheduled to be held on Saturday, May 18, 2019 to inter alia, consider and approve the audited financial results (both Stand-alone and Consolidated) for the year ended  31st March 2019, to consider declaration of dividend, if any, and to consider issue of stock options to employees for 2018-19.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from April 26, 2019 (as already announced) up to end of the day on May 21, 2019.

Intimation about meeting of representative(s) of SAIF Partners, with us at 10.00 A.M. on Thursday, May 02, 2019 at the Corporate Office of the Company, followed by a visit to our Lab.

Intimation that Trading Window shall remain closed for Directors, Employees and Connected Persons from April 26, 2019 until 48 hours after announcement of the financial results for FY 2018-19. The actual date of re-opening of trading window will be notified in due course.

Confirmation of compliance of provisions of Reg. 74(5) of SEBI (Depositories & Participants) Regulations 2018, as certified by the Company’s RTA

Intimation about non-applicability of framework for Fund Raising by issue of Debt Securities by Large Entities notified by SEBI

Intimation that representative(s) of TA Associates, would be having a meeting with us at 2.30 P.M. on Thursday, April 11, 2019 at the Corporate Office of the Company, followed by a visit to our Lab.

Intimation about the following analyst meetings to be held at our corporate office:

i) Meeting with the representative(s) of Arisaig Partners, at 03.00 P.M. on Friday, April 05, 2019, to be followed by a visit by them to our Lab.

ii) Meeting with the representative(s) of Edelweiss Securities Limited, at 3.30 P.M. on Friday, April 05, 2019, to be preceded by a visit by them to our Lab.

Intimation about the following Analyst Meetings:

i) Meeting with the representative(s) of Sands Capital Management, at 12.30 P.M. on Monday, March 25, 2019 at the Corporate Office of the Company, followed by Lab Visit.

ii) Participation of our representative at 1^st Annual Edition of “INDIA IDEATION CONFERENCE” Organized by Motilal Oswal at Hotel Grand Hyatt, Mumbai on Wednesday, March 27, 2019 from 9.00 A.M. to 6.00 P.M, where he will meet representatives of various fund houses.

iii) Meeting with the representative(s) of Goldman Sachs India Securities Ltd., at 3.30 P.M. on Friday, March 29, 2019 at the Corporate Office of the Company.

Intimation about the following Analyst Meetings :

i) Meeting of the representative(s) of Way2Wealth, a Coffee Day Company, at 11.30 A.M. on Wednesday, March 20, 2019 at the Corporate Office of the Company.

ii) Meeting of the representative(s) of SAIF Partners, at 06.00 P.M. on Monday, March 25, 2019 at Hotel Grand  Hyatt, Mumbai.

Intimation about the following Analyst Meetings / Con-call, to be held at our corporate office:

i) Con-call between us and the representatives of Motilal Oswal Mutual Fund, at 3.00 P.M. on Monday, March 11, 2019.

ii) Meeting of the representative(s) of Capital International, at 09.30 A.M. on Tuesday, March 12, 2019.

iii) Meeting of the representative(s) of Seven Canyons Advisors, at 10.00 A.M. on Wednesday, March 13, 2019.

Intimation about the following analyst meetings to be held at our corporate office: 

i) Meeting of the representative(s) of TA Associates, at 10.00 A.M. on Tuesday, February 26, 2019.

ii) Meeting of the representative(s) of Haitong Securities India Private Limited, at 3.30 P.M. on Wednesday, February 27, 2019.

Intimation about the following analyst meetings to be held at our corporate office: 

i) Meeting of the representative(s) of Lohia Securities Limited, at 11.00 A.M. on Monday, February 25, 2019.

ii) Meeting of the representative(s) of TR Capital, at 11.00 A.M. on Tuesday, February 26, 2019.

Post-script of the conference call of Indian and Overseas Investors held on 12-02-2019 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter /nine months ended 31-12-2018 Click here

Intimation about the following analyst meetings to be held at our corporate office: 

i) Meeting of the representative(s) of Consortium Securities Private Limited, at 3.30 P.M. on Friday, February 22, 2019.

ii) Meeting of the representative(s) of Pragya Equities Private Limited, at 5.00 P.M. on Wednesday, February 27, 2019.

Intimation about the following analyst meetings to be held at our corporate office:

i) Meeting of the representative(s) of Ambit Capital Private Limited, at 4.00 P.M. on Wednesday, February 20, 2019.

ii) Meeting of the representative(s) of InvesQ Equity Investment Advisor, at 11.00 A.M. on Thursday, February 21, 2019.

iii) Meeting of the representative(s) of India Ratings & Research Private Limited, a Fitch Group Company, at 4.00 P.M. on Thursday, February 21, 2019.

Intimation that the representative(s) of  SAIF Partners would be having a meeting with us at 1.00 P.M. on Friday, February 15, 2019 at the Corporate Office of the Company.

Intimation that the representatives of Kayne Anderson Rudnick Investment Management LLC, USA and Macquarie Capital Securities (India) Private Limited, would be having a meeting with us at 12.00 Noon on Thursday, February 14, 2019 at the Corporate Office of the Company.

Intimation that representative(s) of SPARX Asset Management, would be having a one-to-one meeting with us at 2.30 P.M. on Tuesday, February 19, 2019 at the Corporate Office of the Company and would also visit our Central Processing Laboratory after the meeting.

Intimation about conference call for Indian and Overseas Investors to be held on 12-02-2019 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / nine months ended 31-12-2018.

Click here to see the Invite